[Pregnancy-specific beta-1-glycoprotein (SP-1) during the second half of pregnancy].
In this paper are defined new data about distribution, controlling factors, metabolism and aspects of physiological function of pregnancy-specific beta 1-glycoprotein during the second half of pregnancy. In high-risk pregnancies with diabetes, Rh-incompatibility and intrauterine death SP-1 concentrations in amniotic fluid were significantly increased. By evaluation of maternal serum concentrations of SP-1 in cases of high-risk pregnancies with EPH-gestosis and fetal retardation relevant results could be demonstrated.
D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D005260:Female; D005313:Fetal Death / Q000378:metabolism; D006023:Glycoproteins / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D010927:Placental Insufficiency / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011254:Pregnancy in Diabetics / Q000378:metabolism; D013997:Time Factors
D006023:Glycoproteins
Das schwangerschaftsspezifische beta 1-Glykoprotein (SP-1) in der 2. Hälfte der Schwangerschaft.